Is it not a burdensome task for a patient suffering from Diabetes to take insulin injections every time before he takes a meal? No doubt, the answer would be a big ‘YES’. Many big players in the pharmaceutical industry have been carrying out extensive research on this, and the day is not too far when the solution to this cumbersome problem will be available in the market.
Diabetes: An Ever Increasing Problem In 2000, an estimated 171 million people worldwide had diabetes (all types). This figure is expected to increase by 144% to 366 million by 2013, as a consequence of increasing longevity, obesity and sedentary lifestyle. The commonest form of Diabetes is Type 2 Diabetes Mellitus (T2DM) , which is outlined by 2 major physiological defects: β-cell dysfunction Insulin resistance Additionally, T2DM is characterized by fasting and postprandial hyperglucagonemia , which contributes to…
